127 related articles for article (PubMed ID: 37418628)
1. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties.
Xiao P; Duan Z; Liu Z; Chen L; Zhang D; Liu L; Zhou C; Gan J; Dong Z; Yang CG
J Med Chem; 2023 Jul; 66(14):9731-9752. PubMed ID: 37418628
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors.
Liu Z; Duan Z; Zhang D; Xiao P; Zhang T; Xu H; Wang CH; Rao GW; Gan J; Huang Y; Yang CG; Dong Z
J Med Chem; 2022 Aug; 65(15):10638-10654. PubMed ID: 35793358
[TBL] [Abstract][Full Text] [Related]
3. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
Huang Y; Su R; Sheng Y; Dong L; Dong Z; Xu H; Ni T; Zhang ZS; Zhang T; Li C; Han L; Zhu Z; Lian F; Wei J; Deng Q; Wang Y; Wunderlich M; Gao Z; Pan G; Zhong D; Zhou H; Zhang N; Gan J; Jiang H; Mulloy JC; Qian Z; Chen J; Yang CG
Cancer Cell; 2019 Apr; 35(4):677-691.e10. PubMed ID: 30991027
[TBL] [Abstract][Full Text] [Related]
4. Chemical Inhibitors Targeting the Oncogenic m
Huang Y; Xia W; Dong Z; Yang CG
Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
[TBL] [Abstract][Full Text] [Related]
5. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
[TBL] [Abstract][Full Text] [Related]
6. [Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid Leukemia --Review].
Fang ZH; Zheng SY; Feng WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):902-906. PubMed ID: 37356958
[TBL] [Abstract][Full Text] [Related]
7. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
[No Abstract] [Full Text] [Related]
8. Rational Design and Optimization of m
Huff S; Kummetha IR; Zhang L; Wang L; Bray W; Yin J; Kelley V; Wang Y; Rana TM
J Med Chem; 2022 Aug; 65(16):10920-10937. PubMed ID: 35939803
[TBL] [Abstract][Full Text] [Related]
9. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m
Qing Y; Dong L; Gao L; Li C; Li Y; Han L; Prince E; Tan B; Deng X; Wetzel C; Shen C; Gao M; Chen Z; Li W; Zhang B; Braas D; Ten Hoeve J; Sanchez GJ; Chen H; Chan LN; Chen CW; Ann D; Jiang L; Müschen M; Marcucci G; Plas DR; Li Z; Su R; Chen J
Mol Cell; 2021 Mar; 81(5):922-939.e9. PubMed ID: 33434505
[TBL] [Abstract][Full Text] [Related]
10. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N
Li Z; Weng H; Su R; Weng X; Zuo Z; Li C; Huang H; Nachtergaele S; Dong L; Hu C; Qin X; Tang L; Wang Y; Hong GM; Huang H; Wang X; Chen P; Gurbuxani S; Arnovitz S; Li Y; Li S; Strong J; Neilly MB; Larson RA; Jiang X; Zhang P; Jin J; He C; Chen J
Cancer Cell; 2017 Jan; 31(1):127-141. PubMed ID: 28017614
[TBL] [Abstract][Full Text] [Related]
11. The Yin and Yang of RNA Methylation: An Imbalance of Erasers Enhances Sensitivity to FTO Demethylase Small-Molecule Targeting in Leukemia Stem Cells.
Van Der Werf I; Jamieson C
Cancer Cell; 2019 Apr; 35(4):540-541. PubMed ID: 30991023
[TBL] [Abstract][Full Text] [Related]
12. The m
Chen LS; Zhang M; Chen P; Xiong XF; Liu PQ; Wang HB; Wang JJ; Shen J
Acta Pharmacol Sin; 2022 May; 43(5):1311-1323. PubMed ID: 34462564
[TBL] [Abstract][Full Text] [Related]
13. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m
Zhou P; Wu M; Ye C; Xu Q; Wang L
J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283
[TBL] [Abstract][Full Text] [Related]
14. m
Huff S; Tiwari SK; Gonzalez GM; Wang Y; Rana TM
ACS Chem Biol; 2021 Feb; 16(2):324-333. PubMed ID: 33412003
[No Abstract] [Full Text] [Related]
15. Glutathione-Bioimprinted Nanoparticles Targeting of N6-methyladenosine FTO Demethylase as a Strategy against Leukemic Stem Cells.
Cao K; Du Y; Bao X; Han M; Su R; Pang J; Liu S; Shi Z; Yan F; Feng S
Small; 2022 Apr; 18(13):e2106558. PubMed ID: 35119204
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach.
Prakash M; Itoh Y; Fujiwara Y; Takahashi Y; Takada Y; Mellini P; Elboray EE; Terao M; Yamashita Y; Yamamoto C; Yamaguchi T; Kotoku M; Kitao Y; Singh R; Roy R; Obika S; Oba M; Wang DO; Suzuki T
J Med Chem; 2021 Nov; 64(21):15810-15824. PubMed ID: 34727689
[TBL] [Abstract][Full Text] [Related]
17. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
18. Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy.
Chen X; Wang Y; Wang JN; Zhang YC; Zhang YR; Sun RX; Qin B; Dai YX; Zhu HJ; Zhao JX; Zhang WW; Ji JD; Yuan ST; Shen QD; Liu QH
EMBO Mol Med; 2024 Feb; 16(2):294-318. PubMed ID: 38297099
[TBL] [Abstract][Full Text] [Related]
19. Structural characteristics of small-molecule inhibitors targeting
Gao S; Li X; Zhang M; Zhang N; Wang R; Chang J
Future Med Chem; 2021 Sep; 13(17):1475-1489. PubMed ID: 34240624
[TBL] [Abstract][Full Text] [Related]
20. R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m
Su R; Dong L; Li C; Nachtergaele S; Wunderlich M; Qing Y; Deng X; Wang Y; Weng X; Hu C; Yu M; Skibbe J; Dai Q; Zou D; Wu T; Yu K; Weng H; Huang H; Ferchen K; Qin X; Zhang B; Qi J; Sasaki AT; Plas DR; Bradner JE; Wei M; Marcucci G; Jiang X; Mulloy JC; Jin J; He C; Chen J
Cell; 2018 Jan; 172(1-2):90-105.e23. PubMed ID: 29249359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
